Glaucoma affects more than 3 million Americans and is the second-leading cause of blindness in the United States. Surgery can treat the disease, but the success rate is low and patients often require a second operation. Now, biomedical researchers have developed a therapy that could dramatically improve the procedure’s outcome.
The disease is marked by a buildup of fluid inside the eye, which exerts pressure on the optic nerve and eventually causes blindness.
Log in
Subscribers, enter your e-mail address for full access to the Science News archives and digital editions.